NEPT

Neptune Wellness Solutions carries an Underweight rating, with a composite score just below 29 and low conviction at 1/5. The pillar mix is decisively weak: fundamentals contribute only 6 points, while regulatory leads at 49, market registers 40, and editorial stands at 30. The regulatory pillar is the strongest because its 50-point jurisdiction posture and 80-point enforcement subscore offset a weak 25-point filing-cadence result. Market support remains incomplete because institutional pricing feeds provide no available quote, while the editorial score reflects no identified newsroom or brief activity in CIN newsroom coverage. The resulting profile lacks a second pillar capable of reinforcing the comparatively stronger regulatory reading.

Licensed fundamentals data show year-over-year revenue contraction of nearly 38%, a negative gross margin of approximately 22%, and an operating margin below negative 230%. Those figures indicate deterioration across sales, unit economics, and operating leverage. Net loss exceeds $53 million, while EBITDA remains negative by more than $45 million, confirming that the stretched financial condition extends beyond noncash accounting effects. A market capitalization below $1 million and a cash-burn ratio approaching 50 further constrain the fundamentals pillar; the 15-point cash-runway subscore does not establish balance-sheet resilience. Primary regulatory filings show no dated latest filing, producing the subdued cadence score, although no regulatory events were recorded over either the latest 90-day or 180-day periods and no enforcement hits were identified.

The clearest forward catalyst sits within the regulatory pillar, where a restored and verifiable filing cadence could convert the company’s strongest existing category into a more durable support for the composite. Current jurisdiction and enforcement subscores already provide the best relative foundation, but absent filing recency prevents that strength from translating into higher conviction. Consistent primary regulatory filings could also provide updated evidence on revenue direction, margin repair, net losses, and cash consumption, enabling a reassessment of the deeply impaired fundamentals pillar. The single most important signal to watch is the appearance of a current, dated primary regulatory filing that reestablishes reporting cadence.